Cns Pharmaceuticals Inc

NASDAQ:CNSP   3:34:35 PM EDT
1.81
+0.02 (+1.12%)
Products

Cns Pharmaceuticals Announces FDA Approval Of IND Application For Its Brain Cancer Drug Candidate Berubicin

Published: 12/17/2020 14:26 GMT
Cns Pharmaceuticals Inc (CNSP) - Cns Pharmaceuticals Announces FDA Approval of Ind Application for Its Brain Cancer Drug Candidate Berubicin.
Cns Pharmaceuticals Inc - Will Initiate Its Trial During Q1 of 2021 to Investigate Efficacy of Berubicin.